Capillary Blood Collection Devices Market Size, Share & Trends Analysis Report By Product (Lancets, Microtainer Capillary Tubes, Microhematocrit Tubes, Warming Devices, Others), By Material (Glass, Plastic, Others), By Applications (Whole Blood Test, Plasma/ Serum Protein Tests, Others), By End-User (Hospitals And Clinics, Blood Donation Centers, Pathology Laboratories, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Capillary Blood Collection Devices Market Size

The global capillary blood collection devices market size was valued at USD 2.40 million in 2024 and is projected to grow from USD 2.59 million in 2025 to reach USD 4.08 million by 2033, growing at a CAGR of 5.9% during the forecast period (2025-2033).

Capillary blood collection devices are specialized tools designed to obtain small blood samples from capillaries through minimally invasive methods such as fingersticks, heel sticks, or earlobe punctures. These devices, including lancets, micro-collection tubes, capillary tubes, and disposable pipettes, are widely used in point-of-care testing, glucose monitoring, and in pediatric or geriatric patients where venous access may be difficult.

The global market is witnessing rapid growth due to increasing demand for point-of-care (POC) testing. These devices offer a less invasive alternative to traditional venipuncture, minimizing patient discomfort while enabling quick and efficient sample collection. Their ability to gather small amounts of blood from capillary-rich areas, such as the fingertip, makes them ideal for rapid diagnostics and self-testing applications.

Moreover, the rising prevalence of anemia—one of the most widespread blood disorders, affecting approximately 25% of the global population—has further fueled the demand for hemoglobin testing, a procedure commonly performed using capillary blood samples at the POC. As the need for efficient and patient-friendly diagnostic solutions continues to grow, capillary blood collection devices are becoming vital in modern healthcare settings.

The below pie chart shows the preference for capillary blood collection in 2024

Source: Straits Research, National Library of Medicine

According to a study conducted by NCBI in 2024, the majority of participants preferred capillary blood collection over venous collection, thus increasing the demand.  Moreover, the need for sophisticated diagnostic tests is generating prospects for manufacturers to bolster their capillary blood collection devices market offerings.

Capillary Blood Collection Devices Market Trends

Shift toward integration of smart technology

The integration of smart technology in capillary blood collection devices is transforming the way blood samples are collected, processed, and analyzed. These advanced devices leverage digital health solutions, including Bluetooth and cloud-based technologies, to provide real-time data to healthcare providers, enabling faster diagnosis and timely interventions. Moreover, wearable blood collection devices are gaining traction as they offer continuous monitoring and a less painful, more convenient method of blood sampling.

• For instance, in May 2023, a study by Noble et al., published in Diagnostics, evaluated Onflow Serum Gel, a needle-free capillary blood collection device from Loop Medical SA. The findings revealed that 96.5% of participants preferred it over venipuncture, highlighting its potential as a pain-free alternative for serum chemistry analysis.

This shift toward smart integration underscores the potential of emerging technologies in revolutionizing blood collection, making it more efficient, patient-friendly, and suitable for critical care applications.

Market Growth Factors

Advancement in capillary blood collection device technology

The advancement in the capillary blood collection devices technology is driven by the rising demand for disease diagnosis and health monitoring, the potential offering of personalized medicine, the rising population demand for healthcare, and the growing prevalence of chronic diseases. As patients seek painless, convenient, and affordable healthcare options, advancing technologies in these devices are becoming an integral part of the healthcare sector, improving patient outcomes.

• For instance, in January 2023, a research article was published by Chiara Volani et al. in the metabolite publication, highlighting advanced capillary blood collection device (VAMS) Volumetric absorptive microsampling, providing minimum invasive, single-drop blood collection suitable for remote sampling, making it a valuable tool for untargeted metabolomics studies with appropriate pre-analytical protocols.

This highlights the importance of innovative and advanced capillary blood collection devices in revolutionizing the diagnostic sector, driving the global market growth.

Adoption of point-of-care diagnostics

As demand for point-of-care diagnostics increases, capillary blood collection devices are gaining popularity since they allow rapid, non-invasive sampling suitable for segregated testing. With POC diagnostics, the need for rapid onsite results in the outpatient setting, rural areas, and home care could reduce one's dependence on classic laboratory environments. Therefore, these devices represent a key product line for meeting this growing demand because they are handheld and user-friendly.

• In January 2025, a study published in the journal Clinical Chemistry and Laboratory Medicine explored how self-sampling devices can enhance point-of-care diagnostics. The research found that capillary blood collection devices, particularly dry blood spots, have gained acceptance because they offer the ability to increase patient empowerment, reduce logistical burdens, and be easily integrated into the laboratory workflow.

This increasing reliance on self-sampling devices is considered one of the most significant drivers of the capillary blood collection market.

Market Restraining Factors

High cost of advanced capillary blood collection devices

The high cost of advanced capillary blood collection devices remains a significant barrier to market adoption, particularly in low- and middle-income healthcare settings. These devices often incorporate innovative technologies such as microsampling, self-sampling functionalities, and digital connectivity to enhance precision and user experience.

However, these advancements drive up production costs, making them less accessible to healthcare providers with limited budgets. Moreover, the expenses associated with regulatory approvals, quality assurance, and integration into existing healthcare infrastructure further add to the financial burden.

As a result, affordability concerns continue to hinder widespread adoption, limiting market growth in cost-sensitive regions.

Market Opportunities

Rising demand for advanced self-monitoring capillary blood collection devices

The demand for advanced self-monitoring capillary blood collection devices is rising due to personalizing health care, the growing prevalence of chronic disease and healthcare needs, painless, convenient, and cost-effective healthcare options, and advancing technologies. These tools make it easy to gather blood samples at home, enabling patients to monitor their health more regularly. Moreover, incorporating cutting-edge technologies like digital interfaces and wireless data transmission improves their functionality by enabling real-time tracking and data sharing with healthcare providers for timely intervention.

• For instance, in September 2022, a study was published by Joshua Zarblet al. on remote self-collection of capillary blood using upper arm devices in the journal BMJ, explaining the feasibility and accuracy of remote self-collection of capillary blood using Tasso+ and TAP II devices for CRP analysis and autoantibody in patients with immune-mediated rheumatic diseases.

Such advancement in self-monitoring capillary blood collection devices is accelerating growth in the capillary blood collection devices market by providing accessibility and cost-effectiveness in the healthcare sector.

Regional Insights

North America: Dominant region with 37.4% market share

North America holds a dominant position in the global capillary blood collection devices market, driven by the adoption of cutting-edge medical technologies, advanced healthcare infrastructure, and high-quality healthcare facilities. The region’s high prevalence of chronic conditions like diabetes and cardiovascular diseases has significantly increased the demand for regular blood monitoring, further propelling the need for capillary blood collection devices. Additionally, the rising focus on preventive healthcare, government policies supporting innovation, and the presence of industry giants such as Becton, Dickinson and Company (BD) and Abbott solidify North America’s leadership in this market.

Asia Pacific: Fastest growing region with the highest market CAGR

Asia-Pacific is projected to experience the highest market growth rate during the forecast period, driven by a surge in demand for advanced healthcare facilities and a large, increasingly health-conscious population. The region’s healthcare infrastructure continues to expand, fueled by both government and private sector investments. Moreover, healthcare awareness programs and initiatives aimed at improving access to care contribute to significant market growth. These combined efforts position Asia-Pacific as the fastest-growing region, offering substantial opportunities for expansion and innovation in the coming years.

Country Insights

• U.S.- The U.S. leads the global market, driven by the rapid adoption of advanced technologies and strong regulatory support. For example, in July 2022, BD's MiniDraw Capillary Blood Collection System received 510(k) clearance from the U.S. FDA. This system enables safe, lab-quality blood collection through a minimally invasive fingerstick procedure, reflecting the U.S.'s ongoing commitment to improving diagnostic efficiency and patient care with innovative solutions.
• Germany– Germany’s market is one of the largest, bolstered by a robust healthcare infrastructure and high rates of chronic diseases like diabetes. The country’s emphasis on research and development also plays a key role. In May 2023, a study by Manchu Umarani Thangavelu et al. in Analytical Science Advances highlighted the growing use of microsampling technologies, showcasing Germany’s leadership in patient-centered healthcare and digital health innovation.
• France- The French market for capillary blood collection devices is expanding due to the rising demand for point-of-care diagnostics and the increasing prevalence of chronic diseases. Moreover, the focus on healthcare R&D is driving market growth. A June 2024 study by Dennis C.W. Poland et al. in Clinical Chemistry and Laboratory Medicine emphasized innovations in blood self-sampling devices, demonstrating France’s efforts to decentralize diagnostics and make healthcare more accessible.
• India– The Indian market is rapidly growing, fueled by the government’s push for advanced healthcare facilities and increasing R&D activities. In August 2021, the S.N. Bose National Centre for Basic Sciences developed AJO-Neo, a non-invasive, no-touch device for newborn bilirubin screening, offering significant advantages over traditional methods. This reflects India’s expanding healthcare capabilities and the country’s growing role in advancing medical technology.
• Saudi Arabia- Saudi Arabia’s market is experiencing growth, driven by a demand for better diagnostic methods and the expansion of healthcare infrastructure. The government’s initiatives to improve patient care, along with the growth of healthcare facilities and diagnostic centers, are fueling this demand. As the country adopts more modern medical technologies, the capillary blood collection market is expected to continue its upward trajectory, boosting national revenue.
• Japan- Japan’s market is expanding due to a growing diagnostic patient population, advanced healthcare facilities, and government initiatives. A key example is Labcorp’s 2022 partnership with BML to expand central laboratory services in Japan. This collaboration, aimed at enhancing clinical trial capabilities and developing companion diagnostics, highlights Japan’s commitment to improving healthcare services and driving market growth through strategic partnerships and cutting-edge medical solutions.

Segmentation Analysis

The global capillary blood collection devices market is segmented into product, material, application, and end-user.

By Product

Lancets lead the market, driven by their widespread medical applications, particularly in diabetes monitoring, as highlighted by the WHO. Their simple design and regulatory approvals, including FDA clearance for home use, make them essential for the rising trend of self-diagnostic testing. Moreover, innovations such as laser lancets are transforming the market.

• A study published in Transfusion (July 2021) compared traditional lancets with the LMT-1000 laser lancing device, demonstrating reduced skin puncture pain and improved donor screening accuracy. These advancements reinforce the adoption of lancets, ensuring trust, safety, and market growth.

By Material

Plastic dominates the market due to its durability, cost-effectiveness, and safety advantages over alternative materials. The adaptability of plastic enables the integration of advanced safety features, such as retractable needles and sterile designs, minimizing contamination risks.

Moreover, plastic's lightweight and disposable nature supports infection control measures, making it the preferred material in healthcare settings. Its role in developing user-friendly, precision-driven devices further strengthens its market dominance, ensuring a balance of convenience, compliance, and innovation in capillary blood collection.

By Application

Whole blood tests hold the leading position in the global market due to their broad applications in diagnosing infections, anemia, and chronic diseases. These tests analyze all blood components, offering critical insights for effective medical assessments. The rising prevalence of diabetes, cardiovascular diseases, and other conditions necessitates frequent blood monitoring, driving demand for whole blood tests. Moreover, advancements in point-of-care testing and home diagnostics further enhance their accessibility, reinforcing their dominance in the market.

By End User

Hospitals and clinics lead the market, as they require precise and efficient blood sampling for diagnostic and therapeutic procedures. The increasing incidence of chronic diseases, such as diabetes and cardiovascular conditions, heightens the need for frequent testing, further driving adoption. These healthcare facilities prioritize accuracy, safety, and efficiency, relying on capillary blood collection devices for rapid results. Moreover, the expansion of hospital networks and diagnostic labs worldwide strengthens their dominance, ensuring continued market growth.

Company Market Share

Key players in the industry are focused on adopting key business strategies, such as strategic collaborations, product approvals, acquisitions, and product launches, to gain a strong foothold in the market.

Greiner Bio-one: An emerging player in the global capillary blood collection devices market

Greiner Bio-one deals in producing, developing, and distributing various product portfolios for the diagnostics and pharmaceutical industries and also provides cutting-edge technologies. They aim to empower customers to contribute to a healthier, cleaner, and safer world.

Recent developments by Greiner Bio-One:

• In March 2022, Greiner Bio-One formed a joint venture, Tracie Healthcare Solutions GmbH, to improve preanalytics through the digitization of sample collection and secure linking of patients and samples for more efficient laboratory analysis.

Recent Developments

• September 2024 – Thermo Fisher Scientific launched the Applied Biosystems InnoviGene Suite, a web-based software platform designed to automate and enhance capillary electrophoresis (CE) data analysis for biopharmaceutical and clinical research labs. This launch is part of Thermo Fisher's strategy to integrate advanced technologies into the capillary blood collection and diagnostic sectors, offering solutions that streamline laboratory workflows, improve accuracy, and accelerate research processes.  

Analyst Opinion

As per our analysts, the global market for capillary blood collection devices is set for remarkable growth, driven by a combination of advanced technological innovations, improved infrastructure, and supportive government programs and initiatives. The widespread adoption of non-invasive, safe, pain-free, and self-sampling devices is playing a pivotal role in advancing the market.

Moreover, emerging economies present significant untapped opportunities, particularly in the Asia-Pacific region. The growing demand for advanced healthcare facilities and services, along with a large, health-conscious population, is expected to drive continued market expansion across the region. This combination of factors positions the global market for sustained growth.